医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

TMD LAB Collaborates With US NIST to Reveal the Secrets of Shape-memory Polymer Materials

2022年11月14日 PM11:00
このエントリーをはてなブックマークに追加


 

SEOUL, South Korea

TMD LAB (CEO Hak-Joon Sung) and the National Institute of Standards and Technology (NIST) under the U.S. Department of Commerce are starting joint research on the properties of SMP materials.

TMD LAB received a Cooperative Research and Development Agreement (CRADA) proposal from the NIST and signed the agreement on October 11 2022. Both sides are expected to build a DNA database for various SMP materials through joint research and develop materials that further reduce the formation of biofilms, thereby enhancing the utility of SMP as implantable medical devices.

TMD LAB and the biomaterials group of NIST signed a confidential disclosure agreement for joint research in April last year. In addition, basic research on the structural properties of SMP of TMD LAB has been conducted.

The biomaterials group of NIST is composed of researchers specialized in various biomaterials and cell-to-cell interactions, microbial measurement, spectroscopy, etc. And they showed a lot of interest in the characteristics of SMP of TMD LAB, which led to the conclusion of CRADA (Cooperative Research and Development. Agreement).

SMP developed by TMD LAB can restore shape near body temperature and control the speed of shape recovery from several seconds to several minutes or more. In addition, it is characterized by reducing the formation of biofilms caused by microbial infection by 74% compared to silicon. TMD LAB is developing various medical devices inserted into the human body, such as non-vascular stents such as external vascular wrapping support and bile duct stent, ophthalmic devices, and plastic implants by utilizing the characteristics of these SMP.

Hak-Joon Sung, CEO of TMD LAB, explained, “I know that it is rare for NIST to sign a joint R&D agreement with a foreign private company. We expect that this joint research would facilitate the expansion of the market for implantable medical devices using SMP.”

About TMD LAB Co., Ltd.

TMD LAB Co., Ltd., established in 2018, is a company that is developing implantable medical devices using Shape Memory Polymer (SMP), high-tech new materials. It has the original technology of polymer synthesis with fast shape restoration near body temperature. Based on this technology, TMD LAB succeeded in performing a procedure with minimal wounds on the human body and resolving the biofilm problem of existing silicone materials.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221114005118/en/

CONTACT

Marketing & Sales Team

HUI GYEONG KIM

+82-02-6216-0080

ask@tmdlab.com

同じカテゴリーの記事 

  • Exergen起诉Baxter International,以捍卫其公布口腔体温计准确性数据的权利
  • Global Oncology Innovator BeiGene Highlights New Data across Hematology and Solid Tumor Portfolio at 2024 ASCO Annual Meeting
  • HighField Biopharmaceuticals Announces Two Abstracts Accepted for the 2024 ASCO Annual Meeting
  • ルベド・ライフ・サイエンシズとバイヤスドルフ、細胞老化に対する新たなスキンケア製品の開発で複数年にわたるパートナーシップを発表
  • Atom Bioscience Enrolling Patients in US as Part of a Global Phase 2b/3 Clinical Trial of a New Investigational Treatment for Chronic Gout